Cargando…

Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis

RATIONALE & OBJECTIVE: Among patients with IgA nephropathy (IgAN), proteinuria and decline in kidney function may be associated with increased economic burden. This study aimed to provide current information on the epidemiology and economic burden of IgAN in the United States. STUDY DESIGN: Retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerma, Edgar V., Bensink, Mark E., Thakker, Kamlesh M., Lieblich, Richard, Bunke, Martin, Rava, Andrew, Wang, Kaijun, Murphy, Michael V., Oliveri, David, Amari, Diana T., Cork, David M.W., Velez, Juan Carlos Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457441/ https://www.ncbi.nlm.nih.gov/pubmed/37637862 http://dx.doi.org/10.1016/j.xkme.2023.100693

Ejemplares similares

Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis
por: Jhaveri, Kenar D., et al.
Publicado: (2023)

Clinicopathological Characteristics of Adult IgA Nephropathy in the United States
por: Caster, Dawn J., et al.
Publicado: (2023)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2013)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
por: Lee, Ji-Hye, et al.
Publicado: (2020)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy
por: Ferrandi, Mara, et al.
Publicado: (2009)

Comment on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Nasri, H.
Publicado: (2014)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017)

Author response on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2014)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
por: Barratt, Jonathan, et al.
Publicado: (2022)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2016)

Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy
por: Kamei, Koichi, et al.
Publicado: (2016)

Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience
por: Imai, N., et al.
Publicado: (2016)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2019)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy
por: Zhou, Jianmei, et al.
Publicado: (2023)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
por: Suh, Jin-Soon, et al.
Publicado: (2020)

Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)
por: Shirai, Sayuri, et al.
Publicado: (2023)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy
por: Hirano, Keita, et al.
Publicado: (2012)

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy
por: LUO, MIAN-NA, et al.
Publicado: (2014)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Immune abnormalities in IgA nephropathy
por: Gentile, Micaela, et al.
Publicado: (2023)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study
por: Gong, Wen-yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h0ubkqakn2q0vmg75kee95937s